Literatur
André MF, Piette JC, Kémény JL, Ninet J, Jego P, Delèvaux I, Wechsler B, Weiller PJ, Francès C, Blétry O, Wismans PJ, Rousset H, Colombel JF, Aumaître O, French Study Group on Aseptic Abscesses (2007) Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine 86(3):145–161
Bissonnette C, Kauzman A, Mainville GN (2017) Oral pyoderma gangrenosum: diagnosis, treatment and challenges: A systematic review. Head Neck Pathol 11(4):427–441
Borda LJ, Wong LL, Marzano AV, Ortega-Loayza AG (2019) Extracutaneous involvement of pyoderma gangrenosum. Arch Dermatol Res 311(6):425–434
Brunsting LA, Goeckerman WH, O’Leary PA (1930) Pyoderma (echthyma) gangrenosum—Clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syph 22:655–680
Cosgarea R, Senilă SC, Badea R, Ungureanu L (2016) Pyoderma gangrenosum with spleen involvement. Review of the literature and case report. J Dermatol Case Rep 10(2):26–31
Gade M, Studstrup F, Andersen AK, Hilberg O, Fogh C, Bendstrup E (2015) Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature. Respir Med 109(4):443–450
Haag C, Hansen T, Hajar T, Latour E, Keller J, Shinkai K, Ortega-Loayza AG (2021) Comparison of three diagnostic frameworks for pyoderma gangrenosum. J Invest Dermatol 141(1):59–63
Hurwitz RM, Haseman JH (1993) The evolution of pyoderma gangrenosum. A clinicopathologic correlation. Am J Dermatopathol 15:28–33
Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M (2017) Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol 176(6):1588–1598
Maverakis E, Marzano AV, Le ST, Callen JP, Brüggen MC, Guenova E, Dissemond J, Shinkai K, Langan SM (2020) Pyoderma gangrenosum. Nat Rev Dis Primers 6(1):81
Müller-Ladner U, Alten R, Heiligenhaus A, Kekow J, Koletzko S, Mrowietz U, Ochsenkühn T, Radke M, Reich K, Rudwaleit M, Schreiber S (2009) „TRECID“: TNFα-assoziierte chronisch entzündliche Erkrankungen. Dtsch Med Wochenschr 134(42):2132–2136
Quist S, Herberger K, Sunderkötter C, Karrer S, Stücker M, Augustin M, Rose C, von Armin U, Alter M, Schorcht A, Kirchesch H, Kreuter A, Worm M, Dissemond J (2020) Pyoderma gangraenosum. S1-Leitlinie der Deutschen Dermatologischen Gesellschaft (DDG). AWMF-Register Nr.: 013-091
Rout AN, Sahu K, Sirka CS (2020) Pyoderma gangrenosum over hypertrophic scar: report of a rare presentation. Indian Dermatol Online J 11(2):222–225
Vadillo M, Jucgla A, Podzamczer D, Rufi G, Domingo A (1999) Pyoderma gangrenosum with liver, spleen and bone involvement in a patient with chronic myelomonocytic leukaemia. Br J Dermatol 141(3):541–543
Wang EA, Steel A, Luxardi G, Mitra A, Patel F, Cheng MY, Wilken R, Kao J, de Ga K, Sultani H, Merleev AA, Marusina AI, Brassard A, Fung MA, Konia T, Shimoda M, Maverakis E (2018) Classic ulcerative pyoderma gangrenosum is a T cell-mediated disease targeting follicular adnexal structures: a hypothesis based on molecular and clinicopathologic studies. Front Immunol 8:1980
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
J. Dissemond gibt an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Dissemond, J. Ist das Pyoderma gangraenosum ausschließlich eine Hauterkrankung?. Hautarzt 72, 451–452 (2021). https://doi.org/10.1007/s00105-021-04758-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-021-04758-9